Citigroup’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-49,000
Closed -$6.49M 6034
2024
Q4
$6.49M Sell
49,000
-107,800
-69% -$10.1M ﹤0.01% 1712
2024
Q3
$8.21M Buy
+156,800
New +$7.36M ﹤0.01% 1454

Other funds holding ALAB

Citigroup's ALAB Position: Q1 2026 in Review

Citigroup increased its Astera Labs (ALAB) stake by 63% in Q1 2026, buying an estimated $83.3M and bringing the position to 1,513,054 shares worth $166M. The position accounts for 0.07% of the portfolio, ranked #254.

Citigroup first reported a position in ALAB in Q2 2024 and has held it in 8 quarters since. The position peaked at $173M in Q3 2025. 703 funds tracked by Wall St. Rank hold ALAB as of Q1 2026.

  • Citigroup held 1,513,054 shares of Astera Labs worth $166M as of Q1 2026.
  • Citigroup bought 584,724 Astera Labs shares in Q1 2026, an estimated $83.3M.
  • Astera Labs made up 0.07% of Citigroup's portfolio in Q1 2026, its #254 holding.
  • Citigroup first reported a position in Astera Labs in Q2 2024 and has held it in 8 quarters since.
  • Citigroup's Astera Labs position peaked at $173M in Q3 2025.
  • 703 funds tracked by Wall St. Rank held Astera Labs as of Q1 2026.

Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.